COX-2-10aa-PGIS gene therapy improves erectile function in rats after cavernous nerve injury

Journal of Sexual Medicine

Volumn 10, Issue 6, 2013, Pages 1476-1487

  Lin, Haocheng ^a,b   Yuan, Jiuhong ^c   Ruan, Ke He ^d   Yang, Wenli ^b   Zhang, Junlan ^b   Dai, Yutian ^a   Wang, Run ^b,e  

^a NANJING UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c SICHUAN UNIVERSITY   (China)

^d UNIVERSITY OF HOUSTON   (United States)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

Cavernous Nerve Injury; COX2 10aa PGIS; Erectile Dysfunction; Penile Rehabilitation; Radical Prostatectomy

Indexed keywords

ADENOVIRUS VECTOR; ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; PROSTACYCLIN SYNTHASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAVERNOUS NERVE INJURY; CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG MECHANISM; EMBRYO; ERECTILE DYSFUNCTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTRACAVERNOSAL PRESSURE; MALE; MEAN ARTERIAL PRESSURE; NERVE CRUSH; NERVE STIMULATION; NICK END LABELING; NONHUMAN; PENIS ERECTION; PRESSURE; PRIORITY JOURNAL; PROSTATECTOMY; RAT; SMOOTH MUSCLE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; WESTERN BLOTTING;

EID: 84878693498     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12147     Document Type: Article

References (36)

1. Jemal ASR, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. Walsh PC, Marschke P, Ricker D, Burnett AL. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 2000;55:58-61.
3. Wang R. Penile rehabilitation after radical prostatectomy: Where do we stand and where are we going? J Sex Med 2007;4:1085-1097.
4. Barry MJ, Gallagher PM, Skinner JS, Fowler FJ Jr. Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of medicare-age men. J Clin Oncol 2012;30:513-518.
5. Yuan J, Westney OL, Ruan KH, Wang R. A new strategy, SuperEnzyme gene therapy in penile rehabilitation. J Sex Med 2009;6(suppl 3):328-333.
6. Ruan KH, Deng H, So SP. Engineering of a protein with cyclooxygenase and prostacyclin synthase activities that converts arachidonic acid to prostacyclin. Biochemistry 2006;45:14003-14011.
7. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB. Arachidonic acid metabolism. Annu Rev Biochem 1986;55:69-102.
8. Bunting S, Gryglewski R, Moncada S, Vane JR. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins 1976;12:897-913.
9. Moncada S, Herman AG, Higgs EA, Vane JR. Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium. Thromb Res 1977;11:323-344.
10. Weksler BB, Ley CW, Jaffe EA. Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A 23187. J Clin Invest 1978;62:923-930.
11. Ingerman-Wojenski C, Silver MJ, Smith JB, Macarak E. Bovine endothelial cells in culture produce thromboxane as well as prostacyclin. J Clin Invest 1981;67:1292-1296.
12. Jakobsson PJ, Thoren S, Morgenstern R, Samuelsson B. Identification of human prostaglandin E synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci U S A 1999;96:7220-7225.
13. Shiri R, Koskimaki J, Hakkinen J, Tammela TL, Auvinen A, Hakama M. Effect of nonsteroidal anti-inflammatory drug use on the incidence of erectile dysfunction. J Urol 2006;175:1812-1815; discussion 1815-6.
14. Cawello W, Schweer H, Muller R, Bonn R, Seyberth HW. Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects. Eur J Clin Pharmacol 1994;46:275-277.
15. Ruan K-H. Hybrid protein that converts arachidonic acid into prostacyclin. Patent application number: 20100015120. 2010.
16. Gassmann M, Grenacher B, Rohde B, Vogel J. Quantifying Western blots: Pitfalls of densitometry. Electrophoresis 2009;30:1845-1855.
17. Mullerad M, Donohue JF, Li PS, Scardino PT, Mulhall JP. Functional sequelae of cavernous nerve injury in the rat: Is there model dependency. J Sex Med 2006;3:77-83.
18. Cellek S, Bivalacqua TJ, Burnett AL, Chitaley K, Lin CS. Common pitfalls in some of the experimental studies in erectile function and dysfunction: A consensus article. J Sex Med 2012;9:2770-2784.
19. Goldner J. A modification of the masson trichrome technique for routine laboratory purposes. Am J Pathol 1938;14:237-243.
20. Muller A, Akin-Olugbade Y, Deveci S, Donohue JF, Tal R, Kobylarz KA, Palese M, Mulhall JP. The impact of shock wave therapy at varied energy and dose levels on functional and structural changes in erectile tissue. Eur Urol 2008;53:635-642.
21. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39:741-748.
22. Burnett AL. Rationale for cavernous nerve restorative therapy to preserve erectile function after radical prostatectomy. Urology 2003;61:491-497.
23. Dean RC, Lue TF. Neuroregenerative strategies after radical prostatectomy. Rev Urol 2005;7(suppl 2):S26-32.
24. Fraiman MC, Lepor H, McCullough AR. Changes in penile morphometrics in men with erectile dysfunction after nerve-sparing radical retropubic prostatectomy. Mol Urol 1999;3:109-115.
25. Walsh PC. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. J Urol 2000;55:58-61.
26. Moreland RB, Traish A, McMillin MA, Smith B, Goldstein I, Saenz de Tejada I. PGE1 suppresses the induction of collagen synthesis by transforming growth factor-beta 1 in human corpus cavernosum smooth muscle. J Urol 1995;153:826-834.
27. Leungwattanakij S, Bivalacqua TJ, Usta MF, Yang DY, Hyun JS, Champion HC, Abdel-Mageed AB, Hellstrom WJ. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl 2003;24:239-245.
28. Granchi S, Vannelli GB, Vignozzi L, Crescioli C, Ferruzzi P, Mancina R, Vinci MC, Forti G, Filippi S, Luconi M, Ledda F, Maggi M. Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells. Mol Hum Reprod 2002;8:1053-1064.
29. Moreland RB, Gupta S, Goldstein I, Traish A. Cyclic AMP modulates TGF-beta 1-induced fibrillar collagen synthesis in cultured human corpus cavernosum smooth muscle cells. Int J Impot Res 1998;10:159-163.
30. Gontero P, Kirby R. Proerectile pharmacological prophylaxis following nerve-sparing radical prostatectomy (NSRP). Prostate Cancer Prostatic Dis 2004;7:223-226.
31. Mulhall JP, Graydon RJ. The hemodynamics of erectile dysfunction following nerve-sparing radical retropubic prostatectomy. Int J Impot Res 1996;8:91-94.
32. Mulhall JP, Slovick R, Hotaling J, Aviv N, Valenzuela R, Waters WB, Flanigan RC. Erectile dysfunction after radical prostatectomy: Hemodynamic profiles and their correlation with the recovery of erectile function. J Urol 2002;167:1371-1375.
33. User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT. Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol 2003;169:1175-1179.
34. McVary KT, Podlasek CA, Wood D, McKenna KE. Apoptotic pathways are employed in neuropathic and diabetic models of erectile dysfunction. J Urol 2006;175:387 (Abstract 1203).
35. Evans DH, Gunderson MP. A prostaglandin, not NO, mediates endothelium-dependent dilation in ventral aorta of shark (Squalus acanthias). Am J Physiol 1998;274:R1050-1057.
36. Goldstein I. Early penile rehabilitation following radical prostatectomy: Overview and rationale. Contemp Urol 2006;18(1 suppl):3-6.